Literature DB >> 18930783

Functional interactions between 7TM receptors in the renin-angiotensin system--dimerization or crosstalk?

Christina Lyngsø1, Niels Erikstrup, Jakob L Hansen.   

Abstract

The Renin-Angiotensin System (RAS) is important for the regulation of cardiovascular physiology, where it controls blood pressure, and salt- and water homeostasis. Dysregulation of RAS can lead to severe diseases including hypertension, diabetic nephropathy, and cardiac arrhythmia, and -failure. The importance of the RAS is clearly emphasised by the widespread use of drugs targeting this system in clinical practice. These include, renin inhibitors, angiotensin II receptor type I blockers, and inhibitors of the angiotensin converting enzyme. Some of the important effectors within the system are 7 transmembrane (7TM) receptors (or G-protein-coupled receptors) such as the angiotensin II Receptors type I and II (AT1R and AT2R) and the MAS-oncogene receptor. Several findings indicate that the 7TM receptors can form both homo- and heterodimers, or higher orders of oligomers. Furthermore, dimerization may be important for receptor function, and in the development of cardiovascular diseases. This is very significant, since "dimers" may provide pharmacologists with novel targets for improved drug therapy. However, we know that 7TM receptors can mediate signals as monomeric units, and so far it has been very difficult to establish if our observations reflect actual well-defined dimerization or merely reflect close proximity between the receptors and/or various types of functional interaction. In this review, we will present and critically discuss the current data on 7TM receptor dimerization with a clear focus on the RAS, and delineate future challenges within the field.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930783     DOI: 10.1016/j.mce.2008.09.018

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  15 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.

Authors:  Gerry T M Wagenaar; Rozemarijn M A Sengers; El Houari Laghmani; Xueyu Chen; Melissa P H A Lindeboom; Anton J M Roks; Gert Folkerts; Frans J Walther
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-06-20       Impact factor: 5.464

3.  Endothelin signalling regulates volume-sensitive Cl- current via NADPH oxidase and mitochondrial reactive oxygen species.

Authors:  Wu Deng; Lia Baki; Clive M Baumgarten
Journal:  Cardiovasc Res       Date:  2010-05-05       Impact factor: 10.787

4.  Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists.

Authors:  Gitte L Christensen; Christian D Kelstrup; Christina Lyngsø; Uzma Sarwar; Rikke Bøgebo; Søren P Sheikh; Steen Gammeltoft; Jesper V Olsen; Jakob L Hansen
Journal:  Mol Cell Proteomics       Date:  2010-04-02       Impact factor: 5.911

Review 5.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

Review 6.  The renin-angiotensin system and cancer: old dog, new tricks.

Authors:  Amee J George; Walter G Thomas; Ross D Hannan
Journal:  Nat Rev Cancer       Date:  2010-10-22       Impact factor: 60.716

7.  Expression and distribution of NADPH oxidase isoforms in human myometrium--role in angiotensin II-induced hypertrophy.

Authors:  Xiao-Lan Cui; Baojun Chang; Leslie Myatt
Journal:  Biol Reprod       Date:  2009-10-07       Impact factor: 4.285

8.  Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex.

Authors:  Leo T O Lee; Stephanie Y L Ng; Jessica Y S Chu; Revathi Sekar; Kaleeckal G Harikumar; Laurence J Miller; Billy K C Chow
Journal:  FASEB J       Date:  2014-03-05       Impact factor: 5.191

9.  The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.

Authors:  Parker C Wilson; Mi-Hye Lee; Kathryn M Appleton; Hesham M El-Shewy; Thomas A Morinelli; Yuri K Peterson; Louis M Luttrell; Ayad A Jaffa
Journal:  J Biol Chem       Date:  2013-05-09       Impact factor: 5.157

10.  Rapid, Facile Detection of Heterodimer Partners for Target Human G-Protein-Coupled Receptors Using a Modified Split-Ubiquitin Membrane Yeast Two-Hybrid System.

Authors:  Yasuyuki Nakamura; Jun Ishii; Akihiko Kondo
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.